Navigation Links
Anastrozole Confirmed Superior in Breast Cancer Prevention
Date:12/14/2007

SAN ANTONIO, Dec. 14 /PRNewswire/ -- Anastrozole is more effective than tamoxifen at preventing breast cancer recurrence for periods of at least 10 years in women with hormone-responsive cancers. In addition, the increased risk of fractures that has been seen in some patients being treated with anastrozole disappears after treatment ends.

Speaking at the Thursday session of the San Antonio Breast Cancer Symposium, Professor John Forbes of the University of Newcastle presented the much-anticipated long-term results of the ATAC (Anastrozole, Tamoxifen, Alone or in Combination) trial that compared 5 years of tamoxifen with 5 years of the aromatase inhibitor anastrozole for the treatment of postmenopausal women with invasive breast cancer.

Hormone-responsive breast cancers require estrogen stimulation in order to grow. Tamoxifen, a synthetic variation of estrogen, binds to hormone receptors on hormone-sensitive cancer cells, preventing estrogen from attaching to the cells. Anastrozole, on the other hand, prevents the manufacture of estrogen by body tissues other than the ovaries (e.g., fat cells), so it is useful for the treatment of hormone-sensitive cancers in postmenopausal women whose ovaries are no longer producing estrogen.

Although previous reports at 33 and 68 months demonstrated that anastrozole was more effective, has fewer serious side effects, and was better tolerated than tamoxifen during the period of treatment, it was not known whether the benefits or side effects associated with anastrozole would persist long term after patients were no longer taking the drug.

After 10 years (5 years after the completion of treatment), patients who had taken anastrozole continued to show reduced rates of tumor recurrence and metastasis compared with patients who had taken tamoxifen. In fact, the relative benefit of anastrozole actually increased compared with results seen immediately after the completion of treatment.

Most striki
'/>"/>

SOURCE San Antonio Breast Cancer Symposium
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Game Commission Announces EHD Confirmed in Fayette County
2. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
3. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
4. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
5. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
8. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
10. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
11. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...USNewswire/ -- Osteoarthritis is a,painful and pot...t 50,million people in the United States. It is ca... The novel investigational pain medication,tapenta...ignificant relief,for patients with joint-disease ...with fewer gastrointestinal side effects than thos...
(Date:5/9/2008)...ewswire/ -- The risk of the two major,prostate dis...H), can be,reduced by changes in lifestyle, such a...d eating a healthy diet. Alan Kristal, Dr.P.H., as...red Hutchinson Cancer Research,Center in Seattle, ...ot,feel helpless against prostate cancer or BPH.,...
(Date:5/9/2008)...Study Shows Positive Results with X-ray ... /- Roche today announced one-year,re...that ACTEMRA(TM),(tocilizumab) can significantly i...in patients with rheumatoid arthritis (RA), a crit...The study also demonstrated that ACTEMRA,reduces d...
(Date:5/8/2008)...lobus Medical, Inc., the largest,privately held sp...nized,leader in motion preservation technology, to...SECURE(R)-C Cervical Artificial Disc IDE study. Th...al motion of the spine in,order to alleviate pain ...n,the treatment of symptomatic cervical disc disea...
Breaking Medicine Technology:Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 2Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 3Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2Mislabeled Supplement Spurred Prostate Cancer 3A Report 9792 1Mislabeled Supplement Spurred Prostate Cancer 3A Report 9792 2Mislabeled Supplement Spurred Prostate Cancer 3A Report 9792 3Gift of Life Celebrates Saving Lives and Setting Records in 2007 9788 1Gift of Life Celebrates Saving Lives and Setting Records in 2007 9788 2Gift of Life Celebrates Saving Lives and Setting Records in 2007 9788 3Cardica to Announce Fiscal 2008 Second Quarter Financial Results on Thursday January 24 2008 9784 1Cardica to Announce Fiscal 2008 Second Quarter Financial Results on Thursday January 24 2008 9784 2In response to a New England Journal of Medicine article published yesterday and subsequent media coverage Eli Lilly and Company issued the following 2665 1In response to a New England Journal of Medicine article published yesterday and subsequent media coverage Eli Lilly and Company issued the following 2665 2In response to a New England Journal of Medicine article published yesterday and subsequent media coverage Eli Lilly and Company issued the following 2665 3In response to a New England Journal of Medicine article published yesterday and subsequent media coverage Eli Lilly and Company issued the following 2665 4
(Date:5/12/2008)...O, May 12 /PRNewswire-FirstCall/ - Med-Emerg Inter... revenue from continuing operations,for the three...pared to,$4.8 million for the same period in 2007 ... the three month period, earnings before,depreciat...roved to $179K,from a loss of ($106K) in 2007. The...
(Date:5/12/2008)...D, Calif., May 12 /PRNewswire-FirstCall/ -- (Nasda...Heart" or the "Corporation") announced,that the To...ay advising it,is reviewing the eligibility for co... WorldHeart under sections 709 and 710(a) of the T...any,s financial condition and,operating results, m...
(Date:5/12/2008)...ONT, Calif., May 12 /PRNewswire/ -- Keck Graduate ...008, commencement ceremony will feature,the gradua...tudent, Eric,Tan, and the unveiling of KGI,s first... of Eric,s achievement in becoming the,first gradu..., KGI,s senior,vice president for academic affairs...
(Date:5/12/2008)...LE, N.Y., May 12 /PRNewswire/ -- Fairbank Farms, a...tary recall of selected ground beef,products produ...gh Price,Chopper, Shaw,s, BJ,s, and Wilson Farms r... affected product may contain small pieces of hard...l-by" date of 05/13/08, 05/15/08, or a,"Julian dat...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. reports improved income from continuing operations 2Health News:Med-Emerg International Inc. reports improved income from continuing operations 3Health News:WorldHeart Notified of TSX Delisting Review 2Health News:KGI 2008 Commencement Features First PhD Graduate, Biotech Painting 2Health News:Fairbank Farms Issues Voluntary Recall for Selected Ground Beef Products 2
...tudy published in the February issue of the Journa... infection does raise the risk of developing preec...also indicate that preeclamptic mothers have low b... who do not have preeclampsia. "We found that chro...
...receive protection from respiratory illness as a r...hantry led research study. As many as 2,277 childr...ths were studied during the course of the research...ly, full breastfeeding for less than one month, fu...
...pt increase in the case of uterine cancer among ol...ates increasing due to better // treatment and d... has been witnessed across Europe. Some of the rea... early puberty, and higher body weight. Overweig...
...d researchers are reported to identified two drugs...otect monkeys from contracting the AIDS virus. // ...ngs also has not yet been confirmed, even though i...re experimented upon by the Centers for Disease an...
Other Medicine News:Health News:Gum Disease Associated With Increased Risk of Preeclampsia 2
The KM-500's unique viewing and alignment window lets you observe the targeted eye from any distance. Two rechargeable batteries provide continuous uninterrupted use. Each battery provides 60 minutes
Non-dissolvable Herrick Lacrimal Plugs provide long-term lacrimal occlusion through partial blockage of the horizontal canaliculus.
Provides quick freezing and quick defrosting by reversible flow of gas system - cleans the probes for every cycle automatically. Lightweight probe tips have high conductivity silver. Useful for Catar
...y reversible flow of gas system - cleans the probe... tips have high conductivity silver. Single footsw...r of the two by a simple selector switch. Surgeon ...and Aspiration together with the double footswitch...
Medicine Products: